Similasan Reisekrankheit, Tabletten - 60 Swissmedic Key 67813001 Registration Holder Similasan AG Name Similasan Reisekrankheit, Tabletten Date of registration 23.11.2021 Introduction of Sequence 23.11.2021 ATC-Classification Antiemetika, Homöopathika (A04AZ) Revision date WHO WHO-DDD Valid until 22.11.2026 Index Therapeuticus (BSV) Show package size 60 Index Therapeuticus (Swissmedic) 20.01.10. Description Swissmedic categorie. D SL Eintrag No Indication Information for professionals Consumer information CI Ex-factory-Price PR Deductible k.A. Consumer price PR Feedback FB GTIN 7680678130013 Medication Code Homöopathische Arzneimittel Pharmacode Disponibility
Composition strychnos nux-vomica (HAB) D15 (Ph.Eur.Hom. 1.1.8) 6.25 mg, hyoscyamus niger (HAB) D15 6.25 mg, petroleum rectificatum (HAB) D15 6.25 mg, anamirta cocculus (HAB) D15 (Ph.Eur.Hom. 1.1.8) 6.25 mg, maydis amylum, magnesii stearas, lactosum monohydricum 241.25 mg, pro compresso 250 mg. Packungsbestandteile Galenic Form Tablets Active Agent Dose Anamirta Cocculus (Hab) D15 (Ph.Eur.Hom. 1.1.8) 6.25 mg Hyoscyamus Niger (Hab) D15 6.25 mg Petroleum Rectificatum (Hab) D15 6.25 mg Strychnos Nux-Vomica (Hab) D15 (Ph.Eur.Hom. 1.1.8) 6.25 mg
Inactive agents Dose Lactose Monohydrate 241.25 mg Magnesii Stearas Maydis Amylum Pro Compresso 250 mg
Source Data was imported : 04.12.2021
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
